Literature DB >> 8211485

Risk-taking behaviour of Cape Peninsula high-school students. Part V. Drug use.

A J Flisher1, C F Ziervogel, D O Chalton, P H Leger, B A Robertson.   

Abstract

The prevalence of a wide range of risk-taking behaviour among high-school students in the Cape Peninsula, South Africa, was investigated. In this article, the results for drug use are presented. Cluster sampling techniques produced a sample of 7,340 students from 16 schools in the three major education departments. A self-administered questionnaire was completed in a normal school period. Estimates for each education department were weighted to produce an overall estimate. Cannabis was the illicit drug most widely used; 7.5% had smoked cannabis, and 2.4% had done so in the previous 7 days. A small subgroup (1.6%) of students had smoked cannabis and methaqualone (Mandrax) together. Reported lifetime use of injectable drugs was 0.5%, and 10.9% had sniffed solvents, 2.6% having done so in the previous 7 days. There were different trends according to gender, standard, and language(s) spoken at home. Of particular note was the small proportion of Xhosa-speaking females who were involved with drug use. The results suggest that the majority of drug use among school students is experimental. A small number of adolescents abuse drugs and are at risk for its associated problems; intervention is indicated for this group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8211485

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

Review 1.  Illicit drug use and treatment in South Africa: a review.

Authors:  Karl Peltzer; Shandir Ramlagan; Bruce D Johnson; Nancy Phaswana-Mafuya
Journal:  Subst Use Misuse       Date:  2010-11       Impact factor: 2.164

2.  Health risk behaviors among high school and university adolescent students.

Authors:  Christina Tsitsimpikou; Konstantinos Tsarouhas; Fotini Vasilaki; Petros Papalexis; Georgios Dryllis; Athanasios Choursalas; Demetrios A Spandidos; Aristides Tsatsakis; Ekaterina Charvalos; Flora Bacopoulou
Journal:  Exp Ther Med       Date:  2018-08-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.